Comparison of clopidogrel and prasugrel as prophylaxis for In-stent protrusion evaluated by optical coherence tomography in patients with ST-segment elevation myocardial infarctio
- Conditions
- ST-segment elevation myocardial infarction
- Registration Number
- JPRN-UMIN000017732
- Lead Sponsor
- Yokohama city university medical center Cardiovascular center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Not provided
(1)Use of oral anticoagulants, ticlodipine, cilostazol and clopidogrel (2)Cardiopulmonary arrest or prolonged CPR (3)Cardiogenic shock (4)STEMI caused by coronary artery bypass graft disease or in-stent restenosis (5)Unsuitable for stent implantation (6)Severe chronic renal failure with serum creatinine >2mg/dL (7)Left main trunk disease (8) Serum hemoglobin level < 9g/dL or >18g/dL Platelet count < 50,000 /mm3 or > 500,000 /mm3 (9) Hematologic or malignant disorder with the life expectancy < 1 year (10)Major bleeding events within 7 days before enrollment (11) Severe liver dysfunction (hepatic cirrhosis or portal hypertension) (12)Drug allergy to aspirin, clopidogrel or prasugrel (13)Women of pregnant, childbearing potential or lactation (14)Participating in the other trial (phase 1-3) (15)Patients who are not allowed to participate in the trial by judgement of the treating physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method